Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Relenza zanamivir (GG167): Phase III trials update

Biota Holdings Ltd. (ASX:BTA; BTAHY), Melbourne, Australia
Product: Relenza zanamivir

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE